Yes. SonoCine AWBUS is an adjunct to mammography for women whose mammograms may be inconclusive due to dense breast tissue and/or implants. Ultrasound and mammography show specific areas of interest differently, and are therefore both [...]
In some cases, benign (non-cancerous) lumps and nodules may be diagnosed from visual characteristics. Ultrasound is an excellent diagnostic tool that may prevent an unnecessary biopsy. But in other cases, you may need a biopsy [...]
You will feel a light pressure as the technologist passes the transducer over your breasts. This is a painless procedure. SonoCine is safe, using only simple sound waves SonoCine is comfortable – No compression No [...]
Insurance coverage depends on the individual's insurance provider and coverage. We currently do not accept insurance, but can provide a superbill which can be used to file a claim with your insurance provider.
New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women, particularly Black and Ashkenazi Jewish women, to have risk assessment by age 25 to determine if screening earlier than age [...]
SonoCine AWBUS technology received FDA clearance in 2008. SonoCine AWBUS has FDA 510k clearance: “The SonoCine Automated Whole Breast Ultrasound System is indicated for use as an adjunct to mammography, but is not intended to [...]
No, the SonoCine uses a computer-guided arm to perform scans, but the ultrasound technician is still present to ensure the arm is properly placed and to guide you through the exam.
No, many lesions are benign, including calcium deposits and fluid-filled cysts. Ultrasound provides greater detail for many lesions suspected of being benign, but in some cases – especially when lesions appear irregular in shape – [...]
Reimbursement will vary depending on the insurance carrier using CPT Code 76641 (ultrasound, breast, unilateral to include axilla when performed, complete) and charged for each breast. Visit SonoCine’s Reimbursement page to learn more.
